Wells Fargo & Company Lumira Dx LTD Transaction History

Wells Fargo & Company

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.15 - $3.05 $45 - $915	-300 Reduced 23.08%	1,000 $1,000
Q2 2022 Aug 12, 2022	BUY	$2.66 - $5.81 $798 - $1,742	300 Added 30.0%	1,300 $3,000
Q1 2022 May 16, 2022	SELL	$6.0 - $10.0 $35,832 - $59,720	-5,972 Reduced 85.66%	1,000 $6,000
Q4 2021 Feb 14, 2022	BUY	$7.29 - $10.49 $787 - $1,132	108 Added 1.57%	6,972 $62,000
Q3 2021 Nov 15, 2021	BUY	$7.94 - $10.14 $54,500 - $69,600	6,864 New	6,864 $57,000

365K

Ticker LMDX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 170,688,000
Market Cap $1.71M
Description
LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care. The compa...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.